TCG
ARKG icon

Transcendent Capital Group’s ARK Genomic Revolution ETF ARKG Stock Holding History

Transcendent Capital Group’s Portfolio ARKG Stock Details ARKG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.14M Buy
+50,957
New +$1.62M 0.83% 40
2025
Q4 		– Sell
-68,185
Closed -$1.89M – 119
2025
Q3 		$1.89M Buy
+68,185
New +$1.72M 0.85% 40

Other funds holding ARKG

JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
JFG
Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $49.6B AUM 39.59% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Transcendent Capital Group's ARKG Position: Q2 2026 in Review

Transcendent Capital Group opened a new position in ARK Genomic Revolution ETF (ARKG) in Q2 2026: 50,957 shares worth $2.14M. The stake represents 0.83% of the portfolio and ranks #40 among its holdings. This is a return to the name: Transcendent Capital Group previously reported a position in ARKG as recently as Q3 2025.

Transcendent Capital Group first reported a position in ARKG in Q3 2025 and has held it in 2 quarters since. 272 funds tracked by Wall St. Rank hold ARKG as of Q2 2026.

  • Transcendent Capital Group held 50,957 shares of ARK Genomic Revolution ETF worth $2.14M as of Q2 2026.
  • ARK Genomic Revolution ETF was a new Transcendent Capital Group position in Q2 2026.
  • ARK Genomic Revolution ETF made up 0.83% of Transcendent Capital Group's portfolio in Q2 2026, its #40 holding.
  • Transcendent Capital Group first reported a position in ARK Genomic Revolution ETF in Q3 2025 and has held it in 2 quarters since.
  • 272 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2026.

Based on Transcendent Capital Group's 13F filing for Q2 2026, filed 5 Aug 2026.